We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Leading drugmaker Amgen could have several growth drivers through the end of the decade. Tepezza remains ...

Initial results found that among 1060 participants in 30 countries, the pembrolizumab plus CCRT group conferred better PFS at 24 months than the placebo plus CCRT group (68% vs 57%; hazard ratio [HR], ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Rory McIlroy needs to win The Masters to complete the career Grand Slam, having won the last of his four major titles at the ...

Three-time Major Champion Pádraig Harrington and PGA TOUR winner Séamus Power have confirmed they will be joining Rory McIlroy and Shane Lowry at the 2025 Amgen Irish Open.

Patients with chronic rhinosinusitis with nasal polyps saw improvements across all endpoints with tezepelumab, according to an abstract presented here. Results were seen as early as 2 and 4 weeks, ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...